Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.
Publisher DOI
PubMed ID
41183774
Abstract
The therapeutic arsenal for treating Crohn's disease has grown rapidly, expanding to include advanced therapies with various modes of action. Over the last two decades, physicians and patients have significantly improved the treatment of Crohn's disease, setting ambitious goals. In 2024, French clinical guidelines were established through a validated process involving the adaptation of international gastroenterology societies' clinical guidelines and French consensus meetings. The French guidelines aimed to ensure the applicability of new approaches in France, taking into account specific restrictions on drug authorization and reimbursement. This position statement outlines the specificity of the French guidelines compared to other international recommendations.
Date Issued
2025-12
Publication Type
Article
Subjects
Crohn’s disease
•
advanced therapy
•
inflammatory bowel disease
•
position paper
Language(s)
en
Author(s)
Amiot, Aurélien | |
Buisson, Anthony | |
Gornet, Jean Marc | |
Fumery, Mathurin | |
Vuitton, Lucine | |
Bourreille, Arnaud | |
Laharie, David | |
Bouguen, Guillaume |
Additional Credits
Journal
Clinics and Research in Hepatology and Gastroenterology
Publisher
Elsevier
ISSN
2210-741X
2210-7401
Access(Rights)
embargo